Method for identification of sensitivity of a patient to telomerase inhibition therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9617583
APP PUB NO 20150152488A1
SERIAL NO

14505366

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GERON CORPORATION3 SYLVAN WAY STE 202 PARSIPPANY NJ 07054

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benedetti, Fabio San Francisco, US 38 508
Elias, Laurence Berkeley, US 40 1174
Harley, Calvin B Murphys, US 45 775
Ratain, Mark J Chicago, US 23 152
Smith, Jennifer Menlo Park, US 37 975

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00